# Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention

> **NCT00285857** · PHASE2 · TERMINATED · sponsor: **Stanford University** · enrollment: 30 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Lovastatin

## Key facts

- **NCT ID:** NCT00285857
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-11
- **Primary completion:** 2010-05
- **Final completion:** 2010-12
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2017-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00285857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00285857, "Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00285857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*